Bariatric‐metabolic surgery for NHS patients with type 2 diabetes in the United Kingdom National Bariatric Surgery Registry
Autor: | Andrew Currie, Roel Bolckmans, Alan Askari, James Byrne, Ahmed R. Ahmed, Rachel L. Batterham, Kamal Mahawar, Alexander Dimitri Miras, Chris M. Pring, Peter K. Small, Richard Welbourn |
---|---|
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Diabetic Medicine. 40 |
ISSN: | 1464-5491 0742-3071 |
DOI: | 10.1111/dme.15041 |
Popis: | Aim Bariatric-metabolic surgery is approved by the National Institute of Health and Care Excellence (NICE) for people with severe obesity and type 2 diabetes (T2DM) (including class 1 obesity after 2014). This study analysed baseline characteristics, disease severity and operations undertaken in people with obesity and T2DM undergoing bariatric-metabolic surgery in the UK National Health Service (NHS) compared to those without T2DM. Methods Baseline characteristics, trends over time and operations undertaken were analysed for people undergoing primary bariatric-metabolic surgery in the NHS using the National Bariatric Surgical Registry (NBSR) for 11 years from 2009 to 2019. Clinical practice before and after the publication of the NICE guidance (2014) was examined. Multivariate logistic regression was used to determine associations with T2DM status and the procedure undertaken. Results 14,948/51,715 (28.9%) participants had T2DM, with 10,626 (71.1%) on oral hypoglycaemics, 4322 (28.9%) on insulin/other injectables, and with T2DM diagnosed 10+ years before surgery in 3876 (25.9%). Participants with T2DM, compared to those without T2DM, were associated with older age (p |
Databáze: | OpenAIRE |
Externí odkaz: |